Machine learning models to predict end-stage kidney disease in chronic kidney disease stage 4
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Machine learning models to predict end-stage kidney disease in chronic kidney disease stage 4 ; volume:24 ; number:1 ; day:19 ; month:12 ; year:2023 ; pages:1-10 ; date:12.2023
BMC nephrology ; 24, Heft 1 (19.12.2023), 1-10, 12.2023
- Creator
-
Takkavatakarn, Kullaya
Oh, Wonsuk
Cheng, Ella
Nadkarni, Girish N.
Chan, Lili
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12882-023-03424-7
- URN
-
urn:nbn:de:101:1-2024030321192762260123
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Takkavatakarn, Kullaya
- Oh, Wonsuk
- Cheng, Ella
- Nadkarni, Girish N.
- Chan, Lili
- SpringerLink (Online service)
Other Objects (12)
Fabry Disease Presenting as End-Stage Kidney Disease
Health-related physical fitness in end-stage kidney disease
Geriatric Assessment in Elderly Patients with End-Stage Kidney Disease
Multilayer network analysis in patients with end-stage kidney disease
Blood Pressure Variability and Frailty in End-Stage Kidney Disease
Barriers to Implementing the Kidney Disease Outcomes Quality Initiative End-Stage Kidney Disease Life Plan Guideline
Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia
Apolipoprotein A5 gene polymorphism (rs662799) and cardiovascular disease in end-stage kidney disease patients
Dysfunction of natural killer cells in end-stage kidney disease on hemodialysis
Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya
LDLR gene polymorphism (rs688) affects susceptibility to cardiovascular disease in end-stage kidney disease patients
Urine 6-bromotryptophan: associations with genetic variants and incident end-stage kidney disease
Fabry Disease Presenting as End-Stage Kidney Disease
Health-related physical fitness in end-stage kidney disease
Geriatric Assessment in Elderly Patients with End-Stage Kidney Disease
Multilayer network analysis in patients with end-stage kidney disease
Blood Pressure Variability and Frailty in End-Stage Kidney Disease
Barriers to Implementing the Kidney Disease Outcomes Quality Initiative End-Stage Kidney Disease Life Plan Guideline
Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia
Apolipoprotein A5 gene polymorphism (rs662799) and cardiovascular disease in end-stage kidney disease patients
Dysfunction of natural killer cells in end-stage kidney disease on hemodialysis
Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya
LDLR gene polymorphism (rs688) affects susceptibility to cardiovascular disease in end-stage kidney disease patients
Urine 6-bromotryptophan: associations with genetic variants and incident end-stage kidney disease
Fabry Disease Presenting as End-Stage Kidney Disease
Health-related physical fitness in end-stage kidney disease
Geriatric Assessment in Elderly Patients with End-Stage Kidney Disease
Multilayer network analysis in patients with end-stage kidney disease
Blood Pressure Variability and Frailty in End-Stage Kidney Disease
Barriers to Implementing the Kidney Disease Outcomes Quality Initiative End-Stage Kidney Disease Life Plan Guideline
Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia
Apolipoprotein A5 gene polymorphism (rs662799) and cardiovascular disease in end-stage kidney disease patients
Dysfunction of natural killer cells in end-stage kidney disease on hemodialysis
Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya
LDLR gene polymorphism (rs688) affects susceptibility to cardiovascular disease in end-stage kidney disease patients